Anti-GPC3/Glypican-3 Antibody (Codrituzumab)
Catalog No.
F1496
Anti-GPC3/Glypican-3 Antibody (Codrituzumab)
Featured Products
Codrituzumab (GC33) is a humanized monoclonal antibody that targets human GPC3 (Glypican-3) with high affinity (Kd of 0.673 nM). GPC3 is an oncofetal protein expressed on the surface of hepatocellular carcinoma (HCC) cells. Codrituzumab induces antibody-dependent cellular cytotoxicity (ADCC) and inhibits tumor growth.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.5 kDa
Dry ice
1365267-33-9
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
RG7686, GC33, Chugai anti-Glypican
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P51654
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Human GPC3 CHOS cells were stained with Anti-GPC3 / Glypican-3 Reference Antibody (codrituzumab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS
GPC3 / Glypican-3
Please avoid freeze-thaw cycles.